Dolutegravir Expanded Access Study (DEAP)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2011 by ViiV Healthcare.
Recruitment status was  Available
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by:
ViiV Healthcare
ClinicalTrials.gov Identifier:
NCT01536873
First received: February 16, 2012
Last updated: February 21, 2012
Last verified: December 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: Expanded access is currently available for this treatment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given